19th Jul 2013 12:18
ADVANCED ONCOTHERAPY Plc
("Advanced Oncotherapy" or "the Company")
Advanced Oncotherapy was informed on 18 July 2013 that, as of 15 July 2013, Mr Michael Horgan was beneficially interested in a total of 36,666,667 ordinary shares in the Company which represents approximately 9.14% of the issued share capital of the Company.
For further information, please visit www.advancedoncotherapy.com or contact:
Michael Sinclair, Chief Executive | Sandy Jamieson | Jon Levinson/Lucy Williams | Simon Hudson |
Advanced Oncotherapy Plc | Libertas Capital Corporate Finance Ltd | Peterhouse Corporate Finance | Tavistock Communications |
(NOMAD & Joint Broker) | (Joint Broker) | (Financial PR & IR) | |
+44 20 3617 8739 | +44 20 3697 9495 | +44 20 7469 0930 | +44 20 7920 3150 |
Related Shares:
AVO.L